Yuyao L. Yi

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.

Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.

Journal: Science translational medicine

Published: February 04, 2026

A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia.

A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Frontiers in immunology

Published: November 04, 2024

Erratum: CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.

Erratum: CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.

Journal: American journal of translational research

Published: January 02, 2024

Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.

Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.

Journal: European journal of medicinal chemistry

Published: December 05, 2022

A systematic review on performance analysis of critical time points in multiple myeloma treated by CAR-T cell immunotherapy.

A systematic review on performance analysis of critical time points in multiple myeloma treated by CAR-T cell immunotherapy.

Journal: International immunopharmacology

Published: October 12, 2022

CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.

CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway.

Journal: American journal of translational research

Published: August 03, 2022

HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells.

HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells.

Journal: Bioactive materials

Published: May 04, 2022

Meta-analysis of efficacy and safety of vitamin D supplementation in the treatment of pulmonary tuberculosis

Meta-analysis of efficacy and safety of vitamin D supplementation in the treatment of pulmonary tuberculosis

Journal: Zhonghua yi xue za zhi

Published: August 25, 2020

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.

Journal: Oncotarget

Published: April 15, 2019

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia.

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 12, 2019

SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules.

SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules.

Journal: Molecular cancer therapeutics

Published: April 16, 2017

A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for Hematological Malignancies.

A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for Hematological Malignancies.

Journal: Acta haematologica

Published: October 26, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026